In southern Tasmania, Australia, primary Epstein-Barr virus infection occurs in adults >30 years of age at a higher frequency (-13% of all cases) than is generally reported for other parts of the world, and -7% of the general population of the region have no antibodies to the virus. Epstein-Barr virus should not be overlooked as a possible cause of disease in older patients in similar populations elsewhere.
In 1986 and 1987, we reviewed the incidence of HA' IM in southern Tasmania and found an unexpectedly high proportion of apparent HA' IM in patients over 30 years of age.
EBV-specific serologic investigations of the general population and IM patients were consequently performed in an effort to evaluate the significance of this finding and the value of the HA test in the diagnosis of primary IM in older patients.
The southern region of Tasmania, the island state of Australia, has a population of approximately 205,740, (102,147 >30 years of age) and is serviced by three pathology laboratories from which data on all patients presenting for the first time with strongly positive HA tests (Monospot; Ortho Diagnostics, Inc., Raritan, N.J.) were (Fig. 1 ). There was no seasonal variation in incidence, and the distributions were similar for both sexes.
It is unlikely that cases in the older age groups were the result of false-positive Monospot tests. Although false-positive results are encountered occasionally in patients with underlying disease (leukemia, lymphoma, rheumatoid arthritis, hepatitis), they occur at a low rate (<1%) (3). To our knowledge, the vast majority of older patients in this study were free of these conditions. Two patients only (in 1986) with severe symptoms of viral hepatitis and for whom tests by the laboratories for EBV-specific immunoglobulin M (IgM) at the time of HA testing were negative were considered to be false-positive. The true incidence of symptomatic infection caused by EBV in older patients may well be even higher than estimated above. With a low index of suspicion, HA testing may not have been performed on some symptomatic older patients. Also, patients with atypical symptoms or initially normal blood counts or patients in whom HA is absent or slow to develop would have been missed. These properties may be more common in older patients (2, 7, 10, 13) .
Since the epidemiological survey was largely a retrospective one, sera from most patients were not available for specific EBV antibody testing. Sera were, however, collected from HA' IM patients towards the end of 1987 and in early 1988 from both adolescent (n = 23) and older (n = 14) groups. Although only 62% (23 of 37) had blood counts typical of or consistent with IM, all had high VCA IgM titers (majority, .320) (Gull Laboratories, Salt Lake City, Utah).
VCA IgG was also detected (the vast majority had titers of -40) (Electro-Nucleonics Inc., Bethesda, Md.). Sera were all negative for rheumatoid factor (Rheumaton; Carter-Wallace, Frenchs Forest, New South Wales, Australia) and cytomegalovirus IgM (Gull). Only one patient (aged 34 years), who was subsequently diagnosed with acute myeloid leukemia, had detectable levels of anti-EBNA antibodies (Gull).
Thus, virus-specific serology strongly suggests that the vast majority of patients, young 
